Ruegg Curtis
EVP, Technical Operations at Revance Therapeutics, Inc.
- Sold, on record
- $792k
- Dollars the filings state
- Form 4 sales
- 24
- Latest Jun 13, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Revance Therapeutics, Inc.EVP, Technical Operations
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Revance Therapeutics, Inc.UnusualJul 17, 2015 2015
Sold 3,000 shares at $31.03 ($93k)
Ruegg Curtis, EVP, Technical Operations
Sold 14.3% of holdings ($652k position)18,027 shares left3x usual sizeFiling
- 2 Form 4 sale Revance Therapeutics, Inc.UnusualAug 17, 2015 +31 days
Sold 3,000 shares at $30.33 ($91k)
Ruegg Curtis, EVP, Technical Operations
Sold 14.3% of holdings ($638k position)18,027 shares left3x usual sizeFiling
- 3 Form 4 sale Revance Therapeutics, Inc.Plan not statedJan 6, 2016 +142 days
Sold 2,000 shares at $33.06 ($66k)
Ruegg Curtis, EVP, Technical Operations
Sold 10% of holdings ($662k position)18,027 shares left2x usual sizeFiling
- 4 Form 4 sale Revance Therapeutics, Inc.Plan not statedFeb 8, 2016 +33 days
Sold 1,000 shares at $18.14 ($18k)
Ruegg Curtis, EVP, Technical Operations
Sold 5.5% of holdings ($331k position)17,264 shares left1x usual sizeFiling
- 5 Form 4 sale Revance Therapeutics, Inc.Plan not statedMar 7, 2016 +28 days
Sold 1,000 shares at $20.43 ($20k)
Ruegg Curtis, EVP, Technical Operations
Sold 3.8% of holdings ($537k position)25,264 shares left1x usual sizeFiling
- 6 Form 4 sale Revance Therapeutics, Inc.Plan not statedApr 11, 2016 +35 days
Sold 1,000 shares at $19.11 ($19k)
Ruegg Curtis, EVP, Technical Operations
Sold 3.8% of holdings ($502k position)25,264 shares left1x usual sizeFiling
- 7 Form 4 sale Revance Therapeutics, Inc.Plan not statedMay 9, 2016 +28 days
Sold 1,000 shares at $16.18 ($16k)
Ruegg Curtis, EVP, Technical Operations
Sold 3.8% of holdings ($425k position)25,264 shares left1x usual sizeFiling
- 8 Form 4 sale Revance Therapeutics, Inc.Plan not statedJun 13, 2016 +35 days
Sold 1,000 shares at $18.25 ($18k)
Ruegg Curtis, EVP, Technical Operations
Sold 4% of holdings ($455k position)23,944 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2016 | Jun 15, 2016 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,000 | $18k | 4.0% | Plan not stated | SEC |
| May 9, 2016 | May 11, 2016 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,000 | $16k | 3.8% | Plan not stated | SEC |
| Apr 11, 2016 | Apr 13, 2016 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,000 | $19k | 3.8% | Plan not stated | SEC |
| Mar 7, 2016 | Mar 9, 2016 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,000 | $20k | 3.8% | Plan not stated | SEC |
| Feb 8, 2016 | Feb 10, 2016 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,000 | $18k | 5.5% | Plan not stated | SEC |
| Jan 6, 2016 | Jan 8, 2016 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 2,000 | $66k | 10.0% | Plan not stated | SEC |
| Aug 17, 2015 | Aug 19, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 3,000 | $91k | 14.3% | Unusual | SEC |
| Jul 17, 2015 | Jul 21, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 3,000 | $93k | 14.3% | Unusual | SEC |
| Jun 17, 2015 | Jun 19, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 3,000 | $101k | 14.3% | Unusual | SEC |
| Jun 3, 2015 | Jun 5, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 500 | $15k | 2.7% | Plan not stated | SEC |
| May 18, 2015 | May 19, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 3,000 | $79k | 13.4% | Unusual | SEC |
| Apr 17, 2015 | Apr 21, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 2,000 | $44k | 9.4% | Plan not stated | SEC |
| Mar 19, 2015 | Mar 23, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 500 | $10k | 2.5% | Plan not stated | SEC |
| Mar 17, 2015 | Mar 19, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,500 | $28k | 7.2% | Plan not stated | SEC |
| Mar 9, 2015 | Mar 11, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 500 | $9k | 2.5% | Plan not stated | SEC |
| Feb 17, 2015 | Feb 18, 2015 | Revance Therapeutics, Inc. | EVP, Technical Operations | Form 4 sale | 1,000 | $17k | 4.9% | Plan not stated | SEC |
| Jan 20, 2015 | Jan 22, 2015 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 1,000 | $17k | 6.6% | Plan not stated | SEC |
| Jan 9, 2015 | Jan 13, 2015 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 500 | $9k | 3.4% | Plan not stated | SEC |
| Dec 17, 2014 | Dec 19, 2014 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 1,000 | $16k | 6.6% | Plan not stated | SEC |
| Dec 9, 2014 | Dec 11, 2014 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 500 | $9k | 3.4% | Plan not stated | SEC |
| Nov 18, 2014 | Nov 20, 2014 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 1,000 | $16k | 6.6% | Plan not stated | SEC |
| Oct 28, 2014 | Oct 30, 2014 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 500 | $10k | 3.6% | Plan not stated | SEC |
| Oct 17, 2014 | Oct 21, 2014 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 1,500 | $28k | 10.2% | Plan not stated | SEC |
| Sep 17, 2014 | Sep 19, 2014 | Revance Therapeutics, Inc. | EVP R&D and Tech Operations | Form 4 sale | 2,000 | $41k | 13.1% | Plan not stated | SEC |